CD19 and lymphoma: The red fluorescence signals from Cy3-labeled aptamer were remarkably strong in CD19-positive Ramos and Raji cells, but weak in CD19-negative cell lines Jurkat and NB-4, again indicating that the aptamer could selectively bind with CD19-positive lymphoma cells in vitro.